News

Thousands of allergy pills recalled

Thousands of allergy pills recalled

RECALLED:Nearly 30,000 allergy tablets are being recalled. Photo: Reuters

MUMBAI (Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy’s Ohm Labs plant in New Jersey, which is the company’s only facility making generics for the United States.

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of medicines.

Rival Indian drugmaker Sun Pharmaceutical Industries Ltd agreed to buy Ranbaxy last month in a $3.2 billion deal, betting it can fix Ranbaxy’s problems.

The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.

Ranbaxy did not immediately respond to requests for comment.

(Reporting by Zeba Siddiqui in MUMBAI; Editing by Subhranshu Sahu)

Recent Headlines

in Entertainment

Amazon plans new streaming service

Fresh
amazon

The new service will compete with Hulu and Netflix.

in Entertainment

REVIEW: Third installment of ‘Hunger Games’ doesn’t disappoint

In this image released by Lionsgate, Jennifer Lawrence portrays Katniss Everdeen, right, and Liam Hemsworth portrays Gale Hawthorne in a scene from "The Hunger Games: Mockingjay Part 1."

Reluctant hero Katniss Everdeen faces the broiling drama of a budding revolution in "The Hunger Games: Mockingjay - Part 1."

in Entertainment

Modern version of ‘All in the Family’ in the works

allinthefamily

The groundbreaking '70s sitcom is being reworked for a 2015 audience.